PROBST; Gary

Patent Applications and Registrations

Patent applications and USPTO patent grants for PROBST; Gary.The latest application filed is for "compounds for the reduction of the deleterious activity of extended nucleotide repeat containing genes".

Company Profile

0.5.15

PROBST; Gary - Redwood City CA
Probst; Gary - Cambridge MA US
Probst; Gary - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds for the Reduction of the Deleterious Activity of Extended Nucleotide Repeat Containing Genes App 20220062233 - SUN; Thomas W. ; et al.	2022-03-03
Substituted cinnolines as inhibitors of LRRK2 kinase activity Grant 9,884,828 - Aubele , et al. February 6, 2	2018-02-06
Inhibitors Of Lrrk2 Kinase Activity App 20150284337 - Aubele; Danielle L. ; et al.	2015-10-08
N-sulfonamido polycyclic pyrazolyl compounds Grant 8,283,358 - Konradi , et al. October 9, 2	2012-10-09
Process for the Production of Fused, Tricyclic Sulfonamides App 20110034691 - Dappen; Michael S. ; et al.	2011-02-10
Substituted hydroxyethylamine aspartyl protease inhibitors Grant 7,858,642 - John , et al. December 28, 2	2010-12-28
N-sulfonamido Polycyclic Pyrazolyl Compounds App 20100081680 - Konradi; Andrei W. ; et al.	2010-04-01
Substituted Hydroxyethylamine Aspartyl Protease Inhibitors App 20090270367 - JOHN; Varghese ; et al.	2009-10-29
Oxime Derivative Substituted Hydroxyethylamine Aspartyl Protease Inhibitors App 20090042961 - John; Varghese ; et al.	2009-02-12
Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors Grant 7,385,085 - John , et al. June 10, 2	2008-06-10
Fused, Tricyclic Sulfonamide Inhibitors of Gamma Secretase App 20080021056 - Konradi; Andrei W. ; et al.	2008-01-24
Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors App 20070149525 - Hom; Roy ; et al.	2007-06-28
Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors App 20070149584 - John; Varghese ; et al.	2007-06-28
Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors App 20060135581 - John; Varghese ; et al.	2006-06-22
Oxime derivative hydroxyethylamine aspartyl-protease inhibitors App 20060128715 - Sealy; Jennifer ; et al.	2006-06-15
Methods of treatment of amyloidosis using spirocyclohexane aspartyl-protease inhibitors App 20060014790 - John; Varghese ; et al.	2006-01-19
Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors App 20050239832 - John, Varghese ; et al.	2005-10-27
Substituted hydroxyethylamine aspartyl protease inhibitors App 20050239836 - John, Varghese ; et al.	2005-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.